Wikidata

(Q65472335)

English

A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

clinical trial

In more languages

Statements

short name
VITAL (English)
0 references
title
A Multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients Treated With Second-Line Docetaxel After Failure of One Platinum Based Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Czech Republic
0 references
Estonia
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
India
0 references
Italy
0 references
Malaysia
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Singapore
0 references
Spain
0 references
Sweden
0 references
Taiwan
0 references
Turkey
0 references
United Kingdom
0 references
start time
September 2007
0 references
end time
January 2011
0 references
number of participants
913
0 references
research site
Sanofi
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65472335&oldid=1858467700"